Shir-jing K. Ho

Shir-jing K. Ho is a doctor who helps people with different types of blood cancers like Marginal Zone Lymphoma, Acute Myelomonocytic Leukemia, B-Cell Lymphoma, Chronic Myelomonocytic Leukemia, and Non-Hodgkin Lymphoma.

Dr. Ho treats patients with care and uses special skills to help them get better. They are good at explaining things in a way that patients can understand, which makes patients trust them.

Dr. Ho stays updated with the latest medical knowledge and research to provide the best care for patients. They read new studies and attend conferences to learn more about treating blood cancers.

Dr. Ho works well with other medical professionals like nurses and other doctors. They share information and work together to give the best care to patients.

Dr. Ho's work has helped many patients live healthier lives. For example, their research on using high-dose methotrexate and cytarabine for primary central nervous system lymphoma has improved outcomes for patients. They also conduct clinical trials like the one with Zanubrutinib for Marginal Zone Lymphoma to find new treatments.

One of Dr. Ho's notable publications talks about how giving certain medicines in a specific order can help patients with primary central nervous system lymphoma. This study was published in a medical journal called EJHaem.

In conclusion, Dr. Ho is a dedicated doctor who uses their skills and knowledge to help patients with blood cancers. They stay updated with the latest research, work well with other medical professionals, and their work has made a positive impact on many patients' lives.